CINECA IRIS Institutional Research Information System

ELISEI, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21382
EU - Europa 11538
AS - Asia 2847
AF - Africa 265
SA - Sud America 65
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 11
Totale 36126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20821
DE - Germania 3146
SE - Svezia 2849
IT - Italia 1810
CN - Cina 1710
BG - Bulgaria 1145
GB - Regno Unito 779
AT - Austria 579
CA - Canada 542
TR - Turchia 444
VN - Vietnam 415
UA - Ucraina 376
FI - Finlandia 293
CI - Costa d'Avorio 237
RU - Federazione Russa 227
IN - India 149
BE - Belgio 98
FR - Francia 54
NL - Olanda 46
BR - Brasile 32
GR - Grecia 26
KR - Corea 22
PL - Polonia 20
EU - Europa 17
ES - Italia 16
ID - Indonesia 16
JP - Giappone 15
RO - Romania 13
HK - Hong Kong 12
AU - Australia 11
IL - Israele 11
CH - Svizzera 10
CL - Cile 10
MX - Messico 10
NG - Nigeria 10
TW - Taiwan 10
CZ - Repubblica Ceca 9
HU - Ungheria 9
IR - Iran 9
IE - Irlanda 8
CR - Costa Rica 6
MA - Marocco 6
PK - Pakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
CO - Colombia 5
RS - Serbia 5
AR - Argentina 4
DK - Danimarca 4
EG - Egitto 4
MY - Malesia 4
PE - Perù 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
EC - Ecuador 3
NO - Norvegia 3
PH - Filippine 3
SG - Singapore 3
TH - Thailandia 3
VE - Venezuela 3
DZ - Algeria 2
EE - Estonia 2
MN - Mongolia 2
SA - Arabia Saudita 2
SV - El Salvador 2
ZA - Sudafrica 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
BD - Bangladesh 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MU - Mauritius 1
PY - Paraguay 1
SC - Seychelles 1
Totale 36126
Salva come PNG Salva come JPEG
Città #
Woodbridge 2876
Fairfield 2816
Chandler 2131
Ann Arbor 1995
Houston 1900
Seattle 1193
Sofia 1144
Ashburn 1122
Wilmington 1055
Cambridge 969
Beijing 693
Vienna 556
Princeton 522
Ottawa 516
Lawrence 448
Jacksonville 439
Medford 360
Izmir 353
Serra 348
Des Moines 279
Nanjing 266
Abidjan 237
Dearborn 191
Dong Ket 188
London 181
San Diego 165
Pisa 148
Frankfurt am Main 142
Boulder 133
Bremen 119
Redwood City 108
Nanchang 100
Brussels 93
Jüchen 78
Kunming 70
Lancaster 63
Düsseldorf 60
Tianjin 59
Changsha 56
Kocaeli 54
Hebei 53
Nürnberg 52
Milan 51
Redmond 51
Norwalk 50
Shenyang 50
Jiaxing 49
Shanghai 41
Falls Church 36
Hefei 36
Detroit 35
Hangzhou 32
Rome 30
Zhengzhou 29
Grafing 27
Jinan 27
Chicago 25
Phoenix 24
Washington 23
Guangzhou 22
Istanbul 22
Auburn Hills 20
Boardman 20
Sacile 19
Verona 19
Munich 18
New York 18
Chengdu 17
Indiana 16
Orange 16
Los Angeles 15
Marseille 15
Napoli 15
Ningbo 15
San Francisco 15
Poltava 14
Wuhan 14
Scandicci 12
Chiesina Uzzanese 11
Dallas 11
Jaboatão 11
Toronto 11
Trieste 11
Florence 10
Lagos 10
Lanzhou 10
Naples 10
Bengaluru 9
Bhavnagar 9
Siena 9
Fremont 8
Jakarta 8
Mumbai 8
Buffalo 7
Cascina 7
Montale 7
San Jose 7
Schiphol 7
Boston 6
Bratislava 6
Totale 25462
Salva come PNG Salva come JPEG
Nome #
Medullary thyroid carcinoma in children 403
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 316
null 259
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 248
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 178
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 174
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. 174
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 171
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 170
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 161
null 160
Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients 159
Ciglitazone induces cell growth inhibition in a medullary thyroid carcinoma cell line (TT) likely by an increase of PPARgamma expression 157
null 157
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 155
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 154
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life 153
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 149
Thyroid carcinoma in thyrotoxic patients treated by surgery. 148
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24 148
null 145
Circulating neuron-specific enolase in medullary thyroid cancer. 144
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line 143
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 141
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 141
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study 140
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure 138
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 138
null 137
Targeted Therapy in Thyroid Cancer: State of the Art 137
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 134
All-trans Retinoic Acid treatment inhibits the growth of RARb mRNA expressing thyroid cancer cell lines but does not re-induce the expression of thyroid specific genes 133
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 132
Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell. 131
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 131
Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. 129
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 129
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. 128
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE 128
Advances in the follow-up of differentiated or medullary thyroid cancer. 127
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 127
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 127
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal 125
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas 124
RET/PTC rearrangements in Belarus, Ukrainian and Russian pos Chernobyl thyroid tumors 124
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 124
RET point mutations in Thyroid Carcinoma 123
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer 122
null 122
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 122
Thyroid cancer in children and adolescents. 121
Genome-wide association study on differentiated thyroid cancer. 121
Prevalence of papillary thyroid cancer (PTC) in patients affected by medullary thyroid cancer (MTC) 120
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 120
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients 119
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 119
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 119
Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. 118
Routine serum calcitonin measurement in the evaluation of thyroid nodules 118
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. 118
Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico. 118
Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid 117
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 117
Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extra-ocular muscle. 116
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 116
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer 115
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer 115
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 115
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma 115
New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. 114
null 114
null 114
T cell responses to orbital antigens in thyroid-associated ophthalmopathy. 113
Il carcinoma tiroideo: nuove prospettive terapeutiche. 113
Thyroid consequences of the Chernobyl nuclear accident. 112
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 112
Interventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer 112
Motesanib diphosphate in progressive differentiated thyroid cancer 110
null 110
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center 110
Definition and management of radioactive iodine-refractory differentiated thyroid cancer 110
Surgical Management of Medullary thyroid carcinoma in pediatric age 110
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 110
Inherited variants in genes somatically mutated in thyroid cancer 109
Demonstration of the existence of the alternatively spliced form of thyroid peroxidase in normal thyroid. 107
Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics. 107
Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy 107
Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice 107
RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma. 107
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer 107
null 107
null 107
Post-surgical follow-up of differentiated thyroid cancer. 106
Anaplastic thyroid cancer therapy: dream or reality? 106
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 106
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 106
Medullary thyroid cancer treated with vandetanib: predictors of longer and durable response 106
Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets. 105
null 105
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 105
Totale 13351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018929 0000 00 00 120224410175
2018/20195164 1655668141 36391 1011136 2638931111866
2019/20208563 974612540551 874945 907642 779652917170
2020/20213725 390248322153 295247 281325 340317246561
2021/20225334 124234126379 1103698 178244 2862183401404
2022/20236934 9771130613612 767917 236705 977000
Totale 36931